https://archive.ph/CFzK4
'On Monday, Mr Streeting reiterated that he was not “comfortable” with the trial, which involves more than 200 people under the age of 16, but said there were significant “checks, balances and safeguards” that made it safe.
He told Sky News: “The thing I’ve had to continually weigh up is that for lots of people who have been through this sort of gender identity treatment, they describe it as life-affirming and life-saving. But there is an understandable degree of public anxiety and concern.
“The crucial reassurance is that not just anyone will be able to sign up to this trial. They will go through extensive assessment by expert clinicians locally that will be reviewed nationally, and every young person would need to assent.
“They’re not old enough to consent. They would need to assent, and they would <a class="break-all" href="https://archive.ph/o/CFzK4/www.telegraph.co.uk/news/2025/12/17/children-cannot-consent-puberty-blocker-trial-wes-streeting/" rel="nofollow" target="_blank">need the consent of parents.
“And so there are lots of checks, balances, oversights and safeguards and constant monitoring in a way that disgracefully wasn’t there before. That’s what gives me the confidence and assurance of knowing this trial is safe.
“There is a debate about whether this is the right thing to do. I understand that, and there’s one thing we’ve learnt about this particular area of policy is that we shouldn’t silence, debate, dissent, disagreement.
“So we’ll continue to have that, and we’ll continue to be subject to scrutiny and challenge.”
Mr Streeting admitted that the children who will be involved in the trial are “very young” and that the drugs are “very strong”.
But he claimed he had tried to take the “politics out of what has been an extremely <a class="break-all" href="https://archive.ph/o/CFzK4/www.telegraph.co.uk/news/2025/11/25/nhs-puberty-blockers-trial-repeat-tavistock-whistleblowers/" rel="nofollow" target="_blank">difficult and sensitive issue”.
Despite the research going ahead, the Health Secretary added: “I think there are still big questions about how we ever ended up in this situation where these sorts of drugs were being routinely prescribed with and we’re continuing to get into that and looking.
“There’ll be another study looking at what’s happened to that cohort of young people over time.”'